Analysis

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis

Amylyx Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to AMLX.

websiteAMLX/analysis/AMLX

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to AMLX.

Stock profile

Ticker

AMLX

Asset type

Stock

Market cap

$1.74B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Amylyx Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • AMLX primary listing

Latest Amylyx Pharmaceuticals, Inc. news

Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026

Amylyx Pharmaceuticals Announces Poster Presentations at ENDO

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical...

CAMBRIDGE, Mass., May 15, 2026--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that Week 24 and Week 48 results from the Phase 2 open-la...

Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

CAMBRIDGE, Mass., May 07, 2026--Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia

CAMBRIDGE, Mass., May 05, 2026--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the launch of a U.S. Expanded Access Program (EAP) for up...

Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its first quarter 2026 financial

Research sections

Valuation

Review valuation context for Amylyx Pharmaceuticals, Inc..

Future growth

Review future growth context for Amylyx Pharmaceuticals, Inc..

Past performance

Review past performance context for Amylyx Pharmaceuticals, Inc..

Financial health

Review financial health context for Amylyx Pharmaceuticals, Inc..

Dividend

Review dividend context for Amylyx Pharmaceuticals, Inc..

Management

Review management context for Amylyx Pharmaceuticals, Inc..

Ownership

Review ownership context for Amylyx Pharmaceuticals, Inc..

Other information

Review other information context for Amylyx Pharmaceuticals, Inc..

Community

Review community context for Amylyx Pharmaceuticals, Inc..